
BIO Technical Analysis Summary (NYSE)
Analyze BIO on the NYSE with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerBIO Technical Analysis Summary (NYSE)
Bio-Rad Laboratories, Inc. (NYSE: BIO) stock currently shows a bullish trend on the NYSE, supported by momentum and strong buying pressure.
Technical conditions suggest Bio-Rad Laboratories, Inc. on the NYSE is awaiting a decisive move. Overall, Bio-Rad Laboratories, Inc. remains neutral, with indicators showing mixed momentum.
RSI (14): 76.72
Stochastic %K: 96.24
Williams %R: -5.74
Rate of Change (ROC): 14.88
Takeaway:Bio-Rad Laboratories, Inc. shows overheated momentum, with risk of near-term pullback.
MACD: 16.03
ADX: 36.44
ATR (14): 11.40
CCI (14): 110.42
Takeaway:Bio-Rad Laboratories, Inc. shows overheated trend conditions, with risk of sharp pullback.
Takeaway:Bio-Rad Laboratories, Inc. trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Bio-Rad Laboratories, Inc. trades near the upper channel, signaling resistance and risk of pullback.
Overall Takeaway:BIO shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
Bearish Signals
MFI above 80 → overbought conditions may limit upside.
Overall Recommendation:Bio-Rad Laboratories, Inc. currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.